Programma finale completo - SIF - Università degli Studi di Torino

204. Role of peroxisome proliferators activated receptors alpha (PPAR-) in acute
pancreatitis induced by cerulean
1 De Sarro Angelina, 1,2 Mazzon E., 1,2 Genovese T., 1,2 Di Paola R., 1 Muià C., 1 Malleo G.,
3‡ Esposito E., Caputi A.P. 1,2 ., Cuzzocrea S. 1,2
1 Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine,
University of Messina, Italy; 2 IRCCS Centro Neurolesi "Bonino-Pulejo", Messina, Italy;
3 Dipartimento di Farmacologia Sperimentale, Università di Napoli “Federico II”, Napoli, Italy
Chemioterapia antibatterica, antivirale e antineoplastica
Poster 21 – 30
205. Analysis of the thymidylate synthase gene structure in colorectal cancer patients,
and its possible relation with the 5-fluorouracil drug response
Sanguedolce Rosario 1 , Gulotta G. 2 , Cajozzo M. 3 , Agrusa A. 2 , Feo S. 4 , Sanguedolce G. 1 ,
Calascibetta A. 1
1 Dipartimento di Scienze Farmacologiche, 2 Chirurgia Generale e d’Urgenza, 3 Dipartimento di
Discipline Chirurgiche ed Oncologiche, 4 DOSAC. University of Studies of Palermo
138
206. Irinotecan metronomic chemotherapy in metastatic colorectal cancer patients: a
pharmacokinetic and pharmacodynamic study
Bocci Guido 1 , Allegrini G. 2 , Fioravanti A. 1 , Orlandi P. 1 , Loupakis Fotios 2 , Barletta M. T. 2 , Di
Paolo A. 1 , Falcone A. 2 , Danesi R. 1 , Del Tacca M. 1
1 Division of Pharmacology and Chemotherapy, Department of Internal Medicine, University of
Pisa, Pisa; 2 Division of Medical Oncology, General Hospital, Livorno
207. Adenosine receptor A3: role and expression in human thyroid cancer
Pinto A., Morello S., Petrella A., Festa M., Popolo A., Parente L., Chiappetta G.*
Department of Pharmaceutical Sciences, University of Salerno, Italy; *Tumor Institute,
Fondazione Senatore G. Pascale, Naples, Italy
208. Antimetastatic effect of a novel non competitive CXCR1/CXCR2 inhibitor in human
melanoma
*Bruno Annalisa, *Mosca M., *Buanne P., °Del Bufalo D., °Desideri M., °Giorgini S., § Ruco L.,
*Allegretti M., *Gloaguen I., *Bizzarri C., * Melillo G., *Bertini R., °Zupi G.
*Dompé pha.r.ma s.p.a., via Campo di Pile, 67100 L’AQUILA, ITALY; °Regina Elena Cancer
Institute, via delle Messi d’Oro 156, 00158 ROME, ITALY; § S.Andrea Hospital, University La
Sapienza, via di Grottarossa 1035, 00189 ROME, ITALY
209. Pharmacokinetics of cisplatin during intraperitoneal hyperthermic chemotherapy
perfusion (IHCP) in patients with peritoneal carcinomatosis
*Cerretani Daniela, *Ferraro M. T., *Fiaschi A. I., *Miceli G. B.,**Cioppa T., **Marrelli
D.,**Corso G.,**Pedrazzani C.,**Roviello F.
*Department of Pharmacology “G. Segre”, University of Siena; **Department of Human
Patology and Oncology, Unit of Surgical Oncolgy, University of Siena
210. Effects of zoledronic acid on cathepsin K circulating levels in patients with bone
metastasis
Leto Gaetano¹, Tumminello F.M¹., Badalamenti G.², Incorvaia L.², Fulfaro F.², Crescimanno
M.¹, Flandina C.¹, Gebbia N.²
¹Lab. Chemioter. Sperimentale and ²U.O. di Oncologia Medica, Dipartimento di Discipline
Chirurgiche ed Oncologiche; Policlinico Universitario P. Giaccone, 90127 Palermo, Italy
pag_sx.indd 1 30/05/2007 5.55.11